Means Investment CO. Inc. Has $1.35 Million Holdings in UnitedHealth Group Incorporated $UNH

Means Investment CO. Inc. reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 31.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,321 shares of the healthcare conglomerate’s stock after selling 1,995 shares during the period. Means Investment CO. Inc.’s holdings in UnitedHealth Group were worth $1,348,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Lakeridge Wealth Management LLC raised its position in UnitedHealth Group by 5.8% in the first quarter. Lakeridge Wealth Management LLC now owns 420 shares of the healthcare conglomerate’s stock valued at $220,000 after purchasing an additional 23 shares during the last quarter. Nabity Jensen Investment Management Inc grew its stake in shares of UnitedHealth Group by 0.9% in the first quarter. Nabity Jensen Investment Management Inc now owns 2,760 shares of the healthcare conglomerate’s stock worth $1,446,000 after purchasing an additional 24 shares during the last quarter. BigSur Wealth Management LLC lifted its holdings in UnitedHealth Group by 0.5% during the 1st quarter. BigSur Wealth Management LLC now owns 4,743 shares of the healthcare conglomerate’s stock worth $2,484,000 after buying an additional 25 shares during the period. Atlantic Edge Private Wealth Management LLC increased its stake in shares of UnitedHealth Group by 8.9% in the first quarter. Atlantic Edge Private Wealth Management LLC now owns 305 shares of the healthcare conglomerate’s stock valued at $160,000 after buying an additional 25 shares during the period. Finally, Stewardship Advisors LLC lifted its stake in shares of UnitedHealth Group by 4.1% in the first quarter. Stewardship Advisors LLC now owns 663 shares of the healthcare conglomerate’s stock worth $347,000 after acquiring an additional 26 shares during the period. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on UNH. Weiss Ratings restated a “sell (d+)” rating on shares of UnitedHealth Group in a research report on Wednesday. JPMorgan Chase & Co. boosted their target price on shares of UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a report on Thursday. Barclays lifted their price objective on UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a research report on Thursday. Royal Bank Of Canada decreased their target price on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a research note on Wednesday, July 30th. Finally, Truist Financial boosted their price target on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research note on Tuesday, September 9th. Sixteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $383.09.

UnitedHealth Group Stock Down 3.6%

Shares of NYSE:UNH opened at $354.30 on Friday. The firm has a market cap of $320.88 billion, a P/E ratio of 15.35, a PEG ratio of 2.29 and a beta of 0.47. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The business’s 50 day simple moving average is $318.21 and its two-hundred day simple moving average is $349.25. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter in the prior year, the business earned $6.80 earnings per share. UnitedHealth Group’s revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.